Milford Biotech Company Plans Another Local Expansion

Milford MA

15 February, 2022

9:58 AM

Description

MILFORD, MA — A planned expansion at a Milford biotechnology facility will head to the Planning Board this week. Nitto Denko Avecia, owned by Japan-based Nitto, is investing about $225 million in its U.S. facilities, including one in Milford along Fortune Boulevard. The facility is Nitto's U.S. headquarters, and serves as a research and development center for oligonucleotides — therapies that use DNA and RNA, similar to the Pfizer and Moderna coronavirus vaccines. The company is in the process of rebuilding its Milford headquarters, which the town signed off on in 2020. The company will go before the Planning Board on Thursday for approval to expand the number of parking spaces at the Fortune Boulevard building. The company wants to add 154 new spaces for a total of 368 spaces.